ATIM-44. A PHASE I FIRST-IN-HUMAN TRIAL OF TWO ADENOVIRAL VECTORS EXPRESSING HSV1-TK AND FLT3L FOR TREATING NEWLY DIAGNOSED RESECTABLE MALIGNANT GLIOMA: THERAPEUTIC REPROGRAMMING O...

nork Lowenstein, Pedro, A Orringer, Daniel, Sagher, Oren, Heth, Jason, Hervey-Jumper, Shawn, Gerald Mammoser, Aaron, Junck, Larry, Leung, Denise, Umemura, Yoshie, Steven Lawrence, Theodore, Miran Kim, Michelle, Richard Wahl, Daniel, McKeever, Paul, Ines Camelo-Piragua, Sandra, Lieberman, Andrew, Venneti, Sriram, Comba, Andrea, Altshuler, David, M Muraszko, Karin, Castro, Maria
Argitaratua izan da Neuro Oncol (2019)